Co-Diagnostics, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Co-Diagnostics, Inc. | CODX - NASDAQ |
$6.35-$6.75 |
$6.00 |
$6.00 | 1.2 million | 7/12/2017 |
WallachBeth Capital, LLC, Network 1 Financial Securities |
Co-Manager(s): |
Health Care |
Filing(s): Filed 2017-04-28 Terms Added 2017-06-09 Updated Prospectus 2017-07-06
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Co-Diagnostics, Inc., and our comprehensive analysis, click "Buy Market Research".
Co-Diagnostics, Inc. Quote & Chart - Click for current quote -
CODX
About Co-Diagnostics, Inc. (adapted from Co-Diagnostics, Inc. prospectus):
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), and to sell diagnostic equipment from other manufacturers as self-contained lab systems.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CODX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved